AAX Biotech

Showing 4 posts of 4 posts found.

AAX Biotech and ToxoTech partner to develop next-gen biotherapeutics for neurological disorders

November 7, 2025
Research and Development AAX Biotech, Biotherapeutics, ToxoTech, neurological disorders

AAX Biotech, a biotech company specialising in next-generation antibody therapeutics, has entered a strategic partnership with ToxoTech, a biopharma company …

AAX Biotech and Daiichi Sankyo partner to evaluate antibody therapeutics

October 31, 2025
AAX Biotech, Daiichi Sankyo, Opti-mAb, Seqitope

AAX Biotech, a Swedish biotechnology company specialising in next-generation antibody therapeutics, has launched a strategic partnership with Daiichi Sankyo, a …

AAX Biotech announces collaboration for cardiovascular antibody therapy

May 8, 2025
Research and Development AAX Biotech, Cardiology, antibody therapies, collaboration, research and development

Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of antibody-based therapies targeting cardiovascular disease. …

AAX Biotech aims to enhance growth with two new appointments

April 10, 2025
Business Development, Recruitment, Research and Development AAX Biotech, Immunology, Oncology, R&D development, antibody therapeutics, business development

AAX Biotech has appointed Ionut Gabriel Dumitru (pictured left) as senior scientist and Kushal Sejwal (pictured right) as business developer, …

The Gateway to Local Adoption Series

Latest content